Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology

Author(s):
Devalla, H.D.; Schwach, V.; Ford, J.W.; Milnes, J.T.; El-Haou, S.; Jackson, C.; Gkatzis, K.; Elliott, D.A.; Lopes, S.M.C.D.; Mummery, C.L. (0000-0002-4549-6535); Verkerk, A.O.; Passier, R.
Published
2015
Publication type
Article / Letter to editor
arrhythmiasatrial cardiomyocytesatrial fibrillationCOUP-TFion channels
Date issued
2015-04-30
Language
English
Is part of
EMBO Molecular Medicine (2015), Vol. 7, no. 4, p. 394-410
hdl
1887/106833